繁體
  • 简体中文
  • 繁體中文
×

熱門資訊> 正文

预测肿瘤学宣布私募3.44亿美元

2025-09-29 21:40

  • Predictive Oncology (NASDAQ:POAI) announced on Monday the pricing of two private placement transactions to support its adoption of a digital asset treasury strategy under which the principal holding will be ATH, the native utility token of the Aethir ecosystem.
  • The company to raise an aggregate of approximately $344.4 million in two private investment in public equity transactions ((PIPEs)) for the purchase and sale of 66.7 million shares of common stock at $0.7751 per share for gross proceeds of $51.7 million and pre-funded warrants to purchase up to 223.6 million shares of common stock for a purchase price equal to the offering price minus $0.01 per pre-funded warrant in exchange for approximately $292.7 million in notional value representing $173.3 million in discounted value, of in-kind contributions of locked and unlocked Aethir tokens. 
  • The pre-funded warrants to be issued in the Crypto PIPE will become exercisable immediately following the company’s receipt of shareholder approval for the exercise of such pre-funded warrants.
  • The PIPEs are expected to close concurrently on or about October 2, 2025.
  • The company intends to use the in-kind contribution of ATH to fund the company’s digital asset treasury strategy and to use the remaining net proceeds from the PIPEs primarily to fund the acquisition of ATH in the open market in further support thereof, as well as for working capital and general corporate purposes.
  • DNA Holdings Venture will serve as the company’s strategic advisor and consultant for the company’s digital asset treasury.
  • POAI is +125.77% to $1.75.
  • Source: Press Release

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
（工作日09：30 - 次日05：30）
客戶端：
關注我們：
  • 微信公眾號二維碼

© 2025 深圳市時代華盛網絡科技有限公司版權所有 粵ICP備16068286號